Please use this identifier to cite or link to this item: https://doi.org/10.1007/s12070-011-0258-y
Title: The MicroFlow Spacer: A Drug-Eluting Stent for the Ethmoid Sinus
Authors: Catalano, P.J.
Thong, M. 
Weiss, R.
Rimash, T.
Keywords: Drug
Elution
Ethmoid
Sinus
Stent
Issue Date: Jul-2011
Citation: Catalano, P.J., Thong, M., Weiss, R., Rimash, T. (2011-07). The MicroFlow Spacer: A Drug-Eluting Stent for the Ethmoid Sinus. Indian Journal of Otolaryngology and Head and Neck Surgery 63 (3) : 279-284. ScholarBank@NUS Repository. https://doi.org/10.1007/s12070-011-0258-y
Abstract: To evaluate the short-term outcomes and safety of a newly introduced drug-eluting ethmoid stent. Prospective study of 23 patients with a total of 40 implanted ethmoid sinuses. Two tertiary care medical facility. Twenty-three patients with medically refractory chronic rhinosinusitis were treated with patient-appropriate endoscopic sinus surgery, with the modification of treating the ethmoid sinuses with an ethmoid stent infused with triamcinolone, instead of conventional endoscopic ethmoidectomy. Patients were then followed up over 6 months. Outcomes were assessed by interval changes in 20-item Sino-Nasal Outcome Test (SNOT-20) and Lund-MacKay CT scores. Safety was determined by adverse events. Overall, the pre-op SNOT-20 mean score was 2. 18, versus post-op score of 1. 02, an improvement of 1. 16 that was both statistically (P < 0. 001) and clinically significant. Ethmoid-specific and side-specific Lund-MacKay mean scores both also showed statistically significant improvements. Pre-op ethmoid-specific Lund-MacKay mean score was 1. 93, versus post-op score of 1. 10, an improvement of 0. 83 (P < 0. 001). Pre-op side-specific Lund-MacKay mean score was 5. 75, compared with post-op score of 2. 95, an improvement of 2. 80 (P < 0. 001). There were no significant intra-op or post-op complications encountered. This triamcinolone-infused ethmoid stent appears safe and effective in treating chronic ethmoid sinus disease within the defined follow-up period. The ability to deliver medication directly to diseased mucosa holds wide-ranging potential. © 2011 Association of Otolaryngologists of India.
Source Title: Indian Journal of Otolaryngology and Head and Neck Surgery
URI: http://scholarbank.nus.edu.sg/handle/10635/125591
ISSN: 22313796
DOI: 10.1007/s12070-011-0258-y
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

15
checked on Dec 11, 2018

WEB OF SCIENCETM
Citations

13
checked on Dec 11, 2018

Page view(s)

18
checked on Nov 16, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.